BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37551635)

  • 1. A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium.
    Hess JL; Mattheisen M; ; Greenwood TA; Tsuang MT; Edenberg HJ; Holmans P; Faraone SV; Glatt SJ
    Am J Med Genet B Neuropsychiatr Genet; 2024 Mar; 195(2):e32957. PubMed ID: 37551635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polygenic resilience score moderates the genetic risk for schizophrenia.
    Hess JL; Tylee DS; Mattheisen M; ; ; Børglum AD; Als TD; Grove J; Werge T; Mortensen PB; Mors O; Nordentoft M; Hougaard DM; Byberg-Grauholm J; Bækvad-Hansen M; Greenwood TA; Tsuang MT; Curtis D; Steinberg S; Sigurdsson E; Stefánsson H; Stefánsson K; Edenberg HJ; Holmans P; Faraone SV; Glatt SJ
    Mol Psychiatry; 2021 Mar; 26(3):800-815. PubMed ID: 31492941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.
    Bigdeli TB; Ripke S; Bacanu SA; Lee SH; Wray NR; Gejman PV; Rietschel M; Cichon S; St Clair D; Corvin A; Kirov G; McQuillin A; Gurling H; Rujescu D; Andreassen OA; Werge T; Blackwood DH; Pato CN; Pato MT; Malhotra AK; O'Donovan MC; Kendler KS; Fanous AH;
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):276-89. PubMed ID: 26663532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain.
    Ivorra JL; Rivero O; Costas J; Iniesta R; Arrojo M; Ramos-Ríos R; Carracedo A; Palomo T; Rodriguez-Jimenez R; Cervilla J; Gutiérrez B; Molina E; Arango C; Alvarez M; Pascual JC; Pérez V; Saiz PA; García-Portilla MP; Bobes J; González-Pinto A; Zorrilla I; Haro JM; Bernardo M; Baca-García E; González JC; Hoenicka J; Moltó MD; Sanjuán J
    Schizophr Res; 2014 Oct; 159(1):107-13. PubMed ID: 25124521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene.
    Nievergelt CM; Maihofer AX; Mustapic M; Yurgil KA; Schork NJ; Miller MW; Logue MW; Geyer MA; Risbrough VB; O'Connor DT; Baker DG
    Psychoneuroendocrinology; 2015 Jan; 51():459-71. PubMed ID: 25456346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).
    Lencz T; Knowles E; Davies G; Guha S; Liewald DC; Starr JM; Djurovic S; Melle I; Sundet K; Christoforou A; Reinvang I; Mukherjee S; DeRosse P; Lundervold A; Steen VM; John M; Espeseth T; Räikkönen K; Widen E; Palotie A; Eriksson JG; Giegling I; Konte B; Ikeda M; Roussos P; Giakoumaki S; Burdick KE; Payton A; Ollier W; Horan M; Donohoe G; Morris D; Corvin A; Gill M; Pendleton N; Iwata N; Darvasi A; Bitsios P; Rujescu D; Lahti J; Hellard SL; Keller MC; Andreassen OA; Deary IJ; Glahn DC; Malhotra AK
    Mol Psychiatry; 2014 Feb; 19(2):168-74. PubMed ID: 24342994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.
    ; Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Brichant-Petitjean C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Pfennig A; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Volkert J; Witt S; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Baune BT
    JAMA Psychiatry; 2018 Jan; 75(1):65-74. PubMed ID: 29121268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
    Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts.
    Whalley HC; Adams MJ; Hall LS; Clarke TK; Fernandez-Pujals AM; Gibson J; Wigmore E; Hafferty J; Hagenaars SP; Davies G; Campbell A; Hayward C; Lawrie SM; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2016 Nov; 6(11):e938. PubMed ID: 27801894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting Schizophrenia Genetics by Utilizing Genetic Overlap With Brain Morphology.
    van der Meer D; Shadrin AA; O'Connell K; Bettella F; Djurovic S; Wolfers T; Alnæs D; Agartz I; Smeland OB; Melle I; Sánchez JM; Linden DEJ; Dale AM; Westlye LT; Andreassen OA; Frei O; Kaufmann T
    Biol Psychiatry; 2022 Aug; 92(4):291-298. PubMed ID: 35164939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
    Nicodemus KK; Hargreaves A; Morris D; Anney R; ; ; Gill M; Corvin A; Donohoe G
    JAMA Psychiatry; 2014 Jul; 71(7):778-785. PubMed ID: 24828433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic associations of neurodevelopmental genes in suicide attempt.
    Sokolowski M; Wasserman J; Wasserman D
    Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
    Li J; Yoshikawa A; Brennan MD; Ramsey TL; Meltzer HY
    Schizophr Res; 2018 Feb; 192():194-204. PubMed ID: 28431800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
    Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
    Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.
    So HC; Chau KL; Ao FK; Mo CH; Sham PC
    Psychol Med; 2019 Jun; 49(8):1286-1298. PubMed ID: 30045777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms.
    Fanous AH; Zhou B; Aggen SH; Bergen SE; Amdur RL; Duan J; Sanders AR; Shi J; Mowry BJ; Olincy A; Amin F; Cloninger CR; Silverman JM; Buccola NG; Byerley WF; Black DW; Freedman R; Dudbridge F; Holmans PA; Ripke S; Gejman PV; Kendler KS; Levinson DF;
    Am J Psychiatry; 2012 Dec; 169(12):1309-17. PubMed ID: 23212062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs.
    Lee SH; DeCandia TR; Ripke S; Yang J; ; ; ; Sullivan PF; Goddard ME; Keller MC; Visscher PM; Wray NR
    Nat Genet; 2012 Feb; 44(3):247-50. PubMed ID: 22344220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk scores in schizophrenia with clinically significant copy number variants.
    Taniguchi S; Ninomiya K; Kushima I; Saito T; Shimasaki A; Sakusabe T; Momozawa Y; Kubo M; Kamatani Y; Ozaki N; Ikeda M; Iwata N
    Psychiatry Clin Neurosci; 2020 Jan; 74(1):35-39. PubMed ID: 31461559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses.
    Euesden J; Breen G; Farmer A; McGuffin P; Lewis CM
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):81-8. PubMed ID: 25656077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.